NCT00707538已完成1 期
A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- Dosimetry analysis following whole body imaging after stress injection
研究概览
简要总结
The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age 18-40
- •BMI 18-30 kg/m2
- •No active or chronic illnesses
- •If female: not pregnant, use of birth control or not of child-bearing potential
排除标准
- •Significant active or chronic illness
- •Any neurological disorder
- •GI disease within 3 months
- •Recent infection
- •Major surgery within 4 weeks
- •Donation of blood within 4 weeks
- •Blood transfusion within 4 weeks
- •Recent history drug/alcohol abuse
- •Head trauma
- •Significant screening ECG, EEG, lab tests, physical exam and vital signs abnormalities
- •Prescription or OTC drugs within 2 weeks
- •Exposure to any other investigational
研究组 & 干预措施
1
Experimental
干预措施: BMS747158 (Drug)
结局指标
主要结局
Dosimetry analysis following whole body imaging after stress injection
时间窗: Imaging takes place approximately 0 - 300 minutes post injection
次要结局
- Safety analysis following vital signs, ECGs, EEG, neuro and physical exams, telephone and visit follow up, and blood draws for chemistry and hematology post injection of BMS747158 at rest and stress(Screening (14 days prior to dosing) through 14 days post dose administration)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158HealthyNCT00707499Lantheus Medical Imaging13
已完成
1 期
Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOXCancerNCT00479583Bristol-Myers Squibb25
招募中
1 期
Application of Al18F-NOTA-Pentixafor PET/CT for Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary AldosteronismNCT06773663Peking Union Medical College Hospital150
已完成
1 期
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid TumorsCancerTumorNCT00329004Bristol-Myers Squibb89
已完成
1 期
Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer PatientsHealthy VolunteersBreast CancerNCT02683083Precirix9